EVOKIWAY
LIVE

Serial Number

79371350

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Apr 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EVOKIWAY Trademark

Serial Number: 79371350 • Registration: 7292518

EVOKIWAY is a trademark filed by NOVARTIS AG on April 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

April 27, 2023

Registration Date

January 30, 2024

Published for Opposition

November 14, 2023

Filing History

NOTIFICATION PROCESSED BY IB
Mar 25, 2024 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 2, 2024 FICS
FINAL DISPOSITION PROCESSED
Mar 1, 2024 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 29, 2024 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Nov 13, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 25, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 25, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 10, 2023 CNSA
ASSIGNED TO EXAMINER
Oct 10, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 18, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 18, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 18, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 18, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 18, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 18, 2023 COAR
APPLICATION FILING RECEIPT MAILED
Jul 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 28, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 8, 2023 REPR